Ginkgo BioWorks Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ginkgo BioWorks Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10551
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ginkgo BioWorks Inc (Ginkgo BioWorks) is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company build’s foundries to scale the process of organism engineering using software and hardware automation tools. It produces ingredients through fermentation with engineered yeasts for perfumes, foods, cosmetics markets; discover new enzymes used in applications including cheesemaking, pharmaceuticals, and stonewashed jeans. It also uses laboratory automation synthesis, software and automation, and high performance analytical tools to produce these products. The company partners with leading bio-industrial fermentation companies such as Ajinomoto and Cargill to improve the efficiency of the microbial strains. Ginkgo BioWorks is headquartered in Boston, Massachusetts, the US.

Ginkgo BioWorks Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Gen9 Raises USD25 Million in Series C Financing 10
Ginkgo Bioworks Secures USD0.12 Million in Seed Funding 11
Gen9 Raises US$0.4 Million In Venture Financing 12
Partnerships 13
Synlogic Enters into Partnership Agreement with Ginkgo BioWorks 13
Licensing Agreements 14
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 14
Acquisition 15
Ginkgo Bioworks Acquires Gen9 15
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 16
Ginkgo BioWorks Inc – Key Competitors 17
Ginkgo BioWorks Inc – Key Employees 18
Ginkgo BioWorks Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Oct 24, 2018: Ginkgo Bioworks opens Bioworks4, adds new tools for the rapid genetic engineering of mammalian cells 20
Corporate Communications 21
Jun 29, 2017: Ginkgo Bioworks Announces New Chief Business Officer and Head of Metabolic Engineering to Support Business Growth 21
Jan 06, 2017: Christian Henry Joins Ginkgo Bioworks Board of Directors 22
Other Significant Developments 23
Jun 27, 2018: Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ginkgo BioWorks Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Gen9 Raises USD25 Million in Series C Financing 10
Ginkgo Bioworks Secures USD0.12 Million in Seed Funding 11
Gen9 Raises US$0.4 Million In Venture Financing 12
Synlogic Enters into Partnership Agreement with Ginkgo BioWorks 13
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 14
Ginkgo Bioworks Acquires Gen9 15
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 16
Ginkgo BioWorks Inc, Key Competitors 17
Ginkgo BioWorks Inc, Key Employees 18
Ginkgo BioWorks Inc, Subsidiaries 19

List of Figures
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ginkgo BioWorks Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ginkgo BioWorks Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TiVo Corp.:企業の戦略・SWOT・財務情報
    TiVo Corp. - Strategy, SWOT and Corporate Finance Report Summary TiVo Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Neurelis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company's product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult p …
  • QBE Insurance (Vietnam) Company Ltd:企業の戦略的SWOT分析
    QBE Insurance (Vietnam) Company Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Lockheed Martin Aeronautics Company:企業の戦略・SWOT・財務分析
    Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Aeronautics Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Nigerian National Petroleum Corporation:企業の戦略的SWOT分析
    Nigerian National Petroleum Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Endava Limited:企業の戦略・SWOT・財務情報
    Endava Limited - Strategy, SWOT and Corporate Finance Report Summary Endava Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sally Beauty Holdings Inc:企業の戦略・SWOT・財務分析
    Sally Beauty Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sally Beauty Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Proximus plc:企業の戦略・SWOT・財務情報
    Proximus plc - Strategy, SWOT and Corporate Finance Report Summary Proximus plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Websol Energy System Ltd (WEBELSOLAR):企業の財務・戦略的SWOT分析
    Summary Websol Energy System Ltd (Websol) is an alternate energy company that offers manufacturing of photovoltaic crystalline solar cells and the related modules. The company offers products such as pv solar cell and pv solar module. Its pv solar cell includes multi crystalline 4bb pv solar cell, m …
  • Avacta Group Plc:企業のM&A・事業提携・投資動向
    Avacta Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Avacta Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • EnviroMission Limited (EVM)-エネルギー分野:企業M&A・提携分析
    Summary EnviroMission Limited (Enviro) is a renewable energy company that develops Solar Tower Technology (STT). It owns the license to STT across the world (excluding in China). The STT integrates the use of solar air collector and central updraft tower, to generate solar induced convective flow. I …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • CITGO Petroleum Corporation:企業の戦略・SWOT・財務情報
    CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SRS Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, urocuff test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables co …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Finance Wales plc:企業のM&A・事業提携・投資動向
    Finance Wales plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finance Wales plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Beach Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Beach Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Beach Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the o …
  • Multiple Myeloma Research Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Multiple Myeloma Research Foundation Inc (MMRF) is a non-profit foundation that develops advanced multiple myeloma treatments. The foundation provides end-to-end solutions for drug discovery and development targeting multiple myeloma. It provides clinical trails such as molecularly targeted …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆